COVID-19 doubles type 2 diabetes risk in children

COVID-19 doubles type 2 diabetes risk in children

Longevity.Technology is growing fast; we are open to conversations with prospective partners and investors who share our vision.

Please get in touch if you are interested:

A recent study has found that children infected with COVID-19 face a significantly higher risk of developing type 2 diabetes. Published in JAMA Network Open, the research reveals that the virus doubles the likelihood of this chronic condition among youth.

The study analyzed data from over 1 million children in Ontario, Canada, tracking their health for about six months. Among these children, those who had contracted COVID-19 were found to be more than twice as likely to be diagnosed with type 2 diabetes compared to those who had not been infected [1].

Researchers suggest the virus may trigger inflammation or disrupt glucose metabolism, leading to diabetes. This is particularly concerning since type 2 diabetes can result in long-term health complications, including heart disease and kidney issues.

The findings raise alarms about the long-term impacts of COVID-19, especially for younger populations. While type 2 diabetes is traditionally linked to obesity, poor diet and lack of physical activity, COVID-19 appears to add another risk factor.

This could mean more young people experiencing the condition earlier than previously thought.

Healthcare providers are encouraged to monitor children who have had COVID-19 for early signs of diabetes [2]. Early detection and intervention are crucial in preventing the progression of the disease and minimizing potential complications.

The study highlights the importance of continued COVID-19 prevention efforts, particularly for children. The link between COVID-19 and type 2 diabetes adds to the growing list of health concerns associated with the virus, emphasizing the need for vigilance even after recovery.

[1] JAMA Network Open. SARS-CoV-2 Infection and New-Onset Type 2 Diabetes Among Pediatric Patients, 2020 to 2022
[2] Cleveland Clinic. COVID-19 and Diabetes in Pediatric Patients: What We Know

Photograph: YuriArcursPeopleimages/Envato

Sign up for our daily newsletter to get our biggest longevity stories, handpicked for you each day.

Big Pharma isn’t building – it’s buying

The latest longevity science, investment, innovation and insight, delivered every morning.

Unlock Longevity Biotech Report for FREE